Jean-Jacques Bienaime

Track

Insider profile

Currently holds positions in Biomarin Pharmaceutical Inc, InterMune Inc and Immunic Inc

Performance

Overall performance
2.9
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
47 55% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -16%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Biomarin Pharmaceutical Inc May 1, 2005 -
Independent Director InterMune Inc March 26, 2012 -
Independent Director Immunic Inc Sept. 20, 2013 -
Independent Director Portola Pharmaceuticals Inc Sept. 1, 2010 - June 30, 2014
Jean-Jacques Bienaime's trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned purchase
Price
187.07
Quantity 39,490 +44.6%
Value US$4,697,049
Transaction date
Purchase
Price
327.10
Quantity 72,678 -13.2%
Value US$1,317,625
Transaction date
Purchase
Price
337.91
Quantity 84,128 -29.2%
Value US$2,034,509
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.27
Quantity 1,000 +2.4%
Value US$19,270
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.27
Quantity 1,000 +2.4%
Value US$19,270
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.46
Quantity 3,500 +9.0%
Value US$68,110
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.46
Quantity 3,500 +9.0%
Value US$68,110
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.48
Quantity 6,000 +18.2%
Value US$116,880
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
19.48
Quantity 6,000 +18.2%
Value US$116,880
US Immunome Inc (IMNM)
Transaction date
Sale
Price
19.41
Quantity 10,000 -23.3%
Value US$194,100
US Immunome Inc (IMNM)
Transaction date
Sale
Price
19.41
Quantity 10,000 -23.3%
Value US$194,100
US Immunome Inc (IMNM)
Transaction date
Sale
Price
19.44
Quantity 500 -1.2%
Value US$9,720
US Immunome Inc (IMNM)
Transaction date
Sale
Price
19.44
Quantity 500 -1.2%
Value US$9,720
Transaction date
Purchase
Price
223.50
Quantity 100 +12.5%
Value US$22,350
Transaction date
Purchase
Price
222.30
Quantity 200 +33.3%
Value US$44,460
Transaction date
Purchase
Price
223.76
Quantity 200 +50.0%
Value US$44,752
Transaction date
Purchase
Price
239.37
Quantity 200 +100.0%
Value US$47,874
Transaction date
Purchase
Price
236.24
Quantity 200 +inf%
Value US$47,247
Transaction date
Planned purchase
Price
10.58
Quantity 1,000 +11.8%
Value US$10,580
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
20.70
Quantity 5,000 +13.0%
Value US$103,500
Transaction date
Planned purchase
Price
11.70
Quantity 1,000 +13.4%
Value US$11,700
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
21.55
Quantity 1,000 +2.7%
Value US$21,550
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
22.12
Quantity 1,000 +2.7%
Value US$22,120
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
9.38
Quantity 5,000 +15.9%
Value US$46,900
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
7.78
Quantity 7,800 +33.0%
Value US$60,684
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
8.21
Quantity 7,000 +42.1%
Value US$57,470
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
13.94
Quantity 7,000 +72.8%
Value US$97,608
Transaction date
Proposed sale
Price
74.54
Quantity 31,000
Value US$2,310,740
Transaction date
Proposed sale
Price
75.19
Quantity 20,000
Value US$1,503,800
US Immunome Inc (IMNM)
Transaction date
Purchase
Price
13.57
Quantity 2,000 +26.3%
Value US$27,140
Transaction date
Proposed sale
Price
81.14
Quantity 20,000
Value US$1,622,800
Transaction date
Proposed sale
Price
81.62
Quantity 20,000
Value US$1,632,400
Transaction date
Proposed sale
Price
91.26
Quantity 20,000
Value US$1,825,200
Transaction date
Proposed sale
Price
90.99
Quantity 20,000
Value US$1,819,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-17
PP Planned purchase
39,490 +44.6%
187.07
US$4,697,049 		39,490 +44.6% 187.07 US$4,697,049
2026-08-18 2026-08-14
B Purchase
72,678 -13.2%
327.10
US$1,317,625 		72,678 -13.2% 327.10 US$1,317,625
2026-08-18 2026-08-14
B Purchase
84,128 -29.2%
337.91
US$2,034,509 		84,128 -29.2% 337.91 US$2,034,509
2026-07-17 2026-07-15
PP Planned purchase
1,000 +5.7%
10.61
US$10,610 		1,000 +5.7% 10.61 US$10,610
2026-06-17 2026-06-15
PP Planned purchase
1,000 +6.0%
10.19
US$10,190 		1,000 +6.0% 10.19 US$10,190
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
1,000 +2.4%
19.27
US$19,270 		1,000 +2.4% 19.27 US$19,270
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
1,000 +2.4%
19.27
US$19,270 		1,000 +2.4% 19.27 US$19,270
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
3,500 +9.0%
19.46
US$68,110 		3,500 +9.0% 19.46 US$68,110
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
3,500 +9.0%
19.46
US$68,110 		3,500 +9.0% 19.46 US$68,110
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
6,000 +18.2%
19.48
US$116,880 		6,000 +18.2% 19.48 US$116,880
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
6,000 +18.2%
19.48
US$116,880 		6,000 +18.2% 19.48 US$116,880
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
10,000 -23.3%
19.41
US$194,100 		10,000 -23.3% 19.41 US$194,100
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
10,000 -23.3%
19.41
US$194,100 		10,000 -23.3% 19.41 US$194,100
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
500 -1.2%
19.44
US$9,720 		500 -1.2% 19.44 US$9,720
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
500 -1.2%
19.44
US$9,720 		500 -1.2% 19.44 US$9,720
2026-06-01 2026-05-29
B Purchase
100 +12.5%
223.50
US$22,350 		100 +12.5% 223.50 US$22,350
2026-06-01 2026-05-29
B Purchase
200 +33.3%
222.30
US$44,460 		200 +33.3% 222.30 US$44,460
2026-06-01 2026-05-29
B Purchase
200 +50.0%
223.76
US$44,752 		200 +50.0% 223.76 US$44,752
2026-05-27 2026-05-26
B Purchase
200 +100.0%
239.37
US$47,874 		200 +100.0% 239.37 US$47,874
2026-05-27 2026-05-26
B Purchase
200 +inf%
236.24
US$47,247 		200 +inf% 236.24 US$47,247
2026-05-19 2026-05-15
PP Planned purchase
1,000 +11.8%
10.58
US$10,580 		1,000 +11.8% 10.58 US$10,580
2026-05-19 2026-05-15
US Immunome Inc (IMNM)
B Purchase
5,000 +13.0%
20.70
US$103,500 		5,000 +13.0% 20.70 US$103,500
2026-04-17 2026-04-15
PP Planned purchase
1,000 +13.4%
11.70
US$11,700 		1,000 +13.4% 11.70 US$11,700
2026-03-12 2026-03-11
US Immunome Inc (IMNM)
B Purchase
1,000 +2.7%
21.55
US$21,550 		1,000 +2.7% 21.55 US$21,550
2026-03-12 2026-03-10
US Immunome Inc (IMNM)
B Purchase
1,000 +2.7%
22.12
US$22,120 		1,000 +2.7% 22.12 US$22,120
2026-03-11 2026-03-09
PP Planned purchase
2,000 +36.7%
11.21
US$22,420 		2,000 +36.7% 11.21 US$22,420
2025-06-03 2025-06-03
US Immunome Inc (IMNM)
B Purchase
5,000 +15.9%
9.38
US$46,900 		5,000 +15.9% 9.38 US$46,900
2025-03-26 2025-03-25
US Immunome Inc (IMNM)
B Purchase
7,800 +33.0%
7.78
US$60,684 		7,800 +33.0% 7.78 US$60,684
2025-03-25 2025-03-24
US Immunome Inc (IMNM)
B Purchase
7,000 +42.1%
8.21
US$57,470 		7,000 +42.1% 8.21 US$57,470
2024-08-19 2024-08-16
US Immunome Inc (IMNM)
B Purchase
7,000 +72.8%
13.94
US$97,608 		7,000 +72.8% 13.94 US$97,608
2024-05-31 2024-05-31
PrS Proposed sale
31,000
74.54
US$2,310,740 		31,000 74.54 US$2,310,740
2024-05-30 2024-05-30
PrS Proposed sale
20,000
75.19
US$1,503,800 		20,000 75.19 US$1,503,800
2024-05-22 2024-05-21
US Immunome Inc (IMNM)
B Purchase
2,000 +26.3%
13.57
US$27,140 		2,000 +26.3% 13.57 US$27,140
2024-05-13 2024-05-10
PlS Planned sale
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-13 2024-05-10
PlS Planned sale
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-10 2024-05-10
PrS Proposed sale
20,000
81.14
US$1,622,800 		20,000 81.14 US$1,622,800
2024-05-13 2024-05-09
PlS Planned sale
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-13 2024-05-09
PlS Planned sale
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-09 2024-05-09
PrS Proposed sale
20,000
81.62
US$1,632,400 		20,000 81.62 US$1,632,400
2024-04-15 2024-04-12
PlS Planned sale
20,000 -4.0%
91.26
US$1,825,200 		20,000 -4.0% 91.26 US$1,825,200
2024-04-12 2024-04-12
PrS Proposed sale
20,000
91.26
US$1,825,200 		20,000 91.26 US$1,825,200
2024-04-15 2024-04-11
PlS Planned sale
20,000 -4.0%
90.99
US$1,819,800 		20,000 -4.0% 90.99 US$1,819,800
2024-04-11 2024-04-11
PrS Proposed sale
20,000
90.99
US$1,819,800 		20,000 90.99 US$1,819,800
2024-03-07 2024-03-06
S Sale
1,000 -0.2%
86.71
US$86,713 		1,000 -0.2% 86.71 US$86,713
2024-03-06 2024-03-06
PrS Proposed sale
1,000
86.71
US$86,713 		1,000 86.71 US$86,713